Piophage, Biopharm-L's patented weapon against MRSA, and other phage therapy products as packaged for over-the-counter sale
Seeing is believing.ABT and its Tbilisi-based production affiliate, Biopharm-L, are working closely together to preserve and enhance the legacy of the defunct Eliava Institute. ABT has a priority contract with Biopharm-L, the only entity licensed and registered to produce commercial phage products in Georgia.
Biopharm-L regularly supplies seven major Georgia pharmacies (including the two largest, PSP and Aversi) with its patented and trademarked commercial phage therapy products, such as Pyophage and Intestiphage, for retail over-the-counter sale. Our products also retail throughout other republics of the former Soviet Union.
Click the links at the end of this paragraph to see full-page descriptions of our products, which continue to demonstrate efficacy in curing a variety of serious bacterial infections such as Streptococcus, Staphylococcus, Escherichia coli (E. coli), Pseudomonas auroginosa, and Proteus.